Bourgoin, France

Our Bourgoin facility is a Center of Excellence for Mid & Late Stage Development and Commercialization of Oral Solid Dose (OSD) products. Working in close collaboration with our Milton Park, UK site, Bourgoin provides fast, flexible small-scale work combined with robust full-scale processes. Bourgoin is our leading EU site for commercialization of oral solid dose products.

Areas of expertise include:

  • Specialized in handling highly potent APIs, including cytostatic
  • Successful transfer and commercialization of development projects for EU, US and Japanese markets
  • Tablets, capsules, powders & granules
  • High potency products
  • FDA approved, including product development services
  • Orphan / Niche indication product
  • HPAPI capabilities up to Cat 3b
  • Non-sexual Hormones

Bourgoin’s commercial capabilities include solid dose manufacturing, packaging, and highly potent handling of:

  • Tablets
  • Capsules
  • Powders & Granules
  • High Potency Products

This site features a strong regulatory inspection history from all major international regulatory agencies. Additionally, we are also making continued investments in the site both in capital and scientific resources.

Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.